Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

J&J's Invokana shines in PhII Type 1 diabetes study--but raises the risk of serious side effects, too
Fierce Pharma
Mon, 06/13/16 - 07:10 pm
Tags:
JNJ, Invokana, type 1 diabetes, Janssen
Ethicon study reports bariatric surgery as effective treatment for Asian Indian type II patients
Mass Device
Mon, 06/13/16 - 07:06 pm
Tags:
Ethicon, JNJ, devices, bariatric surgery
Johnson & Johnson recruits top Zika researcher to Houston
Bizjournals.com
Sun, 06/12/16 - 12:28 pm
Tags:
JNJ, R&D, Zika virus, Houston
Johnson & Johnson: Can Anything Slow It Down?
Seeking Alpha
Sun, 06/12/16 - 12:27 pm
Tags:
JNJ
J&J preparing to launch a new mealtime insulin delivery patch
Bizjournals.com
Sun, 06/12/16 - 12:24 pm
Tags:
JNJ, diabetes, insulin, OneTouch Via
Will the approval of Inflectra be a biosimilar adoption tipping point?
BioPharma Dive
Fri, 06/10/16 - 10:18 am
Tags:
Inflectra, biosimilars, Celltrion, Remicade, JNJ, rheumatoid arthritis
J&J, GSK rheumatoid arthritis drug meets goals of large trial
Yahoo/Reuters
Wed, 06/8/16 - 10:06 am
Tags:
JNJ, GSK, rheumatoid arthritis, clinical trials, sirukumab
Johnson & Johnson Courting Huge Revenue Potential In Multiple Myeloma Space
Seeking Alpha
Tue, 06/7/16 - 11:12 am
Tags:
JNJ, Multiple Myeloma, daratumumab, ASCO 2016
Two former device maker execs go on trial for unauthorized marketing
Stat
Tue, 06/7/16 - 11:11 am
Tags:
devices, JNJ, Acclarent
3 Biotechs Expecting Market-Moving Trial Results Soon
Motley Fool
Mon, 06/6/16 - 11:07 am
Tags:
biotech, Ophthotech, Achillion, Kite Pharma, odalasvir, JNJ, Fovista, KTE-C19
J&J myeloma drug, in combo regimen, delays worsening of the disease
Yahoo/Reuters
Sun, 06/5/16 - 12:01 pm
Tags:
JNJ, Multiple Myeloma, Darzalex, Takeda, Velcade, ASCO 2016
Why Johnson & Johnson Paid $3 Billion for Shampoo
Investopedia
Thu, 06/2/16 - 10:43 pm
Tags:
JNJ, M&A
Samsung Bioepis notches European Commission nod for Remicade biosim
Fierce Pharma
Mon, 05/30/16 - 11:05 am
Tags:
Samsung Bioepis, Europe, Flixabi, Remicade, biosimilars, JNJ
Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline
Motley Fool
Mon, 05/30/16 - 10:13 am
Tags:
JNJ, Pfizer, Novartis, Merck, Bristol-Myers Squibb, GSK, Sanofi, AbbVie, Eli Lilly, AstraZeneca
J&J sued by two states, alleging hidden vaginal mesh risks
Stat
Wed, 05/25/16 - 09:27 pm
Tags:
JNJ, pelvic mesh, devices, California, Washington
Achillion's Pipeline Strengthens, With Near-Term Potential Catalysts
Seeking Alpha
Wed, 05/25/16 - 11:31 am
Tags:
Achillion, ACH-4471, JNJ, hepatitis C
Janssen's multiple myeloma drug passes muster in Europe
BioPharma Dive
Tue, 05/24/16 - 11:42 pm
Tags:
Janssen, Multiple Myeloma, Europe, JNJ, Darazalex
Behind the World’s Top Drugmakers’ Approach to Zika Vaccine
Bloomberg
Tue, 05/24/16 - 11:15 am
Tags:
Zika virus, vaccines, R&D, JNJ, Sanofi, GSK, Merck
Samsung Bioepis applies for approval to sell Remicade biosimilar in U.S.
Yahoo/Reuters
Mon, 05/23/16 - 09:41 pm
Tags:
Samsung Bioepis, Remicade, biosimilars, FDA, rheumatoid arthritis, JNJ
Medtronic Buys The Right Kind Of Morcellators
Seeking Alpha
Sat, 05/21/16 - 12:27 pm
Tags:
Medtronic, devices, laparoscopic power morcellators, JNJ, Smith & Nephew

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.